Enrique Conterno

Enrique Conterno currently serves as a Board Member for Zealand Pharma and Glooko since November and September 2023, respectively. Prior to these roles, Enrique held the position of Chief Executive Officer at FibroGen, Inc. from January 2020 to August 2023. Enrique's extensive experience at Eli Lilly and Company spanned from June 2006 to December 2019, where responsibilities included President of Lilly Diabetes & Lilly USA, President of Lilly Diabetes, and Vice President of Health Care Professional Markets, focusing on neuroscience, diabetes, and osteoporosis in the U.S. Enrique also served as Vice President of U.S. Neuroscience. Enrique holds an MBA from Duke University's Fuqua School of Business.